| Literature DB >> 32435172 |
Prasanta Patra1, Niladri Mondal1, Bidhan Chandra Patra1,2, Manojit Bhattacharya1,2.
Abstract
Nocardia asteroides is the main causative agent responsible for nocardiosis disease in immunocompromised patient viz. Acquired Immunodeficiency Syndrome (AIDS), malignancy, diabetic, organ recipient and genetic disorders. The virulence factor and outer membrane protein pertains immense contribution towards the designing of epitopic vaccine and limiting the robust outbreak of diseases. While epitopic based vaccine element carrying B and T cell epitope along with adjuvant is highly immunoprophylactic in nature. Present research equips immunoinformatics to figure out the suitable epitopes for effective vaccine designing. The selected epitopes VLGSSVQTA, VNIELKPEF and VVPSNLFAV amino acids sequence are identified by HLA-DRB alleles of both MHC class (MHC-I and II) molecules. Simultaneously, these also accessible to B-cell, confirmed through the ABCPred server. Antigenic property expression is validated by the Vaxijen antigenic prediction web portal. Molecular docking between the epitopes and T cell receptor delta chain authenticate the accurate interaction between epitope and receptor with significantly low binding energy. Easy access of epitopes to immune system also be concluded as transmembrane nature of the protein verified by using of TMHMM server. Appropriate structural identity of the virulence factor Mce-family protein generated through Phyre2 server and subsequently validated by ProSA and PROCHECK program suite. The structural configuration of theses epitopes also shaped using DISTILL web server. Both the structure of epitopes and protein will contribute a significant step in designing of epitopic vaccine against N. asteroides. Therefore, such immunoinformatics based computational drive definitely provides a conspicuous impel towards the development of epitopic vaccine as a promising remedy of nocardiosis. © Springer Nature B.V. 2019.Entities:
Keywords: Epitope; Immunocompromised; Immunoinformatics; Nocardiosis; Protein; Vaccine
Year: 2019 PMID: 32435172 PMCID: PMC7223102 DOI: 10.1007/s10989-019-09921-4
Source DB: PubMed Journal: Int J Pept Res Ther ISSN: 1573-3149 Impact factor: 1.931
Predicted B-cell epitopes of virulence factor Mce-family protein by ABCpred server
| Serial no. | Sequence position in protein | Epitopic sequence | Score |
|---|---|---|---|
| 1 | 377–396 | AIPGLTTPGIAPMQTANGTE | 0.94 |
| 2 | 329–338 | PRYGDLLGPSCFTAPSEVSL | 0.93 |
| 3 | 144–163 | VRDILNEVDPVQLGRVLGTL | 0.89 |
| 4 | 273–292 | LGALAADPGSITKTFDVFGP | 0.85 |
| 5 | 419–438 | GLLGGGAPAPAAGPAAAPAD | 0.83 |
| 6 | 358–377 | KALASAAGLPPLVAIPGMPA | 0.83 |
| 7 | 215–234 | ELLDVLGSSVQTANTIATKR | 0.83 |
| 8 | 394–413 | GTEVKPFAGTPLEGLVPPIQ | 0.82 |
| 9 | 52–71 | DVKFRGVLVGVVKDVEIVDK | 0.81 |
| 10 | 178–197 | IQRLDHWLTTVADAGPNLGG | 0.81 |
| 11 | 112–131 | FNGASNQYLHEGSQIPEDTS | 0.81 |
| 12 | 68–87 | IVDKGTVQKVNIELKPEFAG | 0.80 |
| 13 | 461–480 | QLLGRKPTASEFLLLGPIMK | 0.79 |
| 14 | 94–113 | TARVVPSNLFAVTSVELVFN | 0.77 |
| 15 | 76–95 | KVNIELKPEFAGDIPANVTA | 0.77 |
| 16 | 59–78 | LVGVVKDVEIVDKGTVQKVN | 0.76 |
| 17 | 408–427 | LVPPIQLPGLPGLLGGGAPA | 0.75 |
| 18 | 387–406 | APMQTANGTEVKPFAGTPLE | 0.75 |
| 19 | 16–35 | ALILGFLMARYQGYFVPKVN | 0.75 |
| 20 | 133–152 | GTVALQDTLTTVRDILNEVD | 0.75 |
Common MHC epitopes within the B-cell epitope
| Serial no. | Common epitopic sequence of ABCpred, ProPred and ProPred-I | Number of ProPred predicted MHC-II allele recognize the epitope | Number of ProPred-I predicted MHC-I allele recognize the epitope | Sequence start point |
|---|---|---|---|---|
| 1 | IAPMQTANG | 9 | 5 | 386 |
| 2 | VQLGRVLGT | 14 | 9 | 154 |
| 3 | LVAIPGMPA | 25 | 4 | 369 |
| 4 | VLGSSVQTA | 13 | 8 | 219 |
| 5 | VKPFAGTPL | 7 | 8 | 397 |
| 6 | FRGVLVGVV | 21 | 11 | 55 |
| 7 | FNGASNQYL | 4 | 7 | 112 |
| 8 | VNIELKPEF | 6 | 7 | 77 |
| 9 | FLLLGPIMK | 27 | 10 | 472 |
| 10 | VVPSNLFAV | 14 | 14 | 97 |
| 11 | VEIVDKGTV | 11 | 11 | 65 |
| 12 | YQGYFVPKV | 14 | 11 | 26 |
| 13 | VALQDTLTT | 7 | 10 | 135 |
Vaxijen predicted antigenic and non antigenic common B and T-cell epitopes
| Serial no. | Sequence | Antigenic prediction | Score |
|---|---|---|---|
| 1 | IAPMQTANG | Non antigen | 0.7176 |
| 2 | VQLGRVLGT | Non antigen | − 0.1922 |
| 3 | LVAIPGMPA | Non antigen | 0.3552 |
| 4 | |||
| 5 | VKPFAGTPL | Non antigen | 0.1380 |
| 6 | FRGVLVGVV | Non antigen | − 0.4871 |
| 7 | FNGASNQYL | Non antigen | 0.7069 |
| 8 | |||
| 9 | FLLLGPIMK | Non antigen | 0.6999 |
| 10 | |||
| 11 | VEIVDKGTV | Non antigen | − 0.3870 |
| 12 | YQGYFVPKV | Non antigen | − 0.3972 |
| 13 | VALQDTLTT | Non antigen | 0.6264 |
| Threshold score = 1.0 | |||
Values in bold are beyond the threshold score = 1.0, these are Antigenic
Selected common B and T-cell antigenic epitope
| 9mer epitopes | Antigenic score |
|---|---|
| VLGSSVQTA | 1.1110 |
| VNIELKPEF | 2.4569 |
| VVPSNLFAV | 1.0810 |
Fig. 1a 3D structure of VLGSSVQTA epitope. b 3D structure of VNIELKPEF epitope. c 3D structure of VVPSNLFAV epitope
Fig. 2Tertiary structure of the protein virulence factor Mce family protein
Fig. 3All atom presentation of virulence factor Mce family protein model in Ramachandran plot by PROCHECK server
Plot statistics of all atoms of virulence factor Mce family protein
| Type of amino acids | Total no | ||
|---|---|---|---|
| Non Glycine and non Proline residues | |||
| Amino acids position | Number | Percentage (%) | |
| Favoured region | 92 | 79.3 | 116 |
| Additional allowed region | 16 | 13.8 | |
| Generously allowed region | 6 | 5.2 | |
| Disallowed region | 2 | 1.7 | |
| End-residues | 2 | ||
| Glycine residues | 13 | ||
| Proline residues | 6 | ||
| Total residues | 137 | ||
Fig. 4Predicted model (black dot) of virulence factor Mce family protein within the Z-score range of ProSA plot
Fig. 5Energy plot of amino acids of virulence factor Mce family protein by ProSA prediction server
Fig. 6Predicted transmembrane helix localization by TMHMM server
Representation of geometric shape complimentary score, area of interaction and ACE value of the epitope receptor docking complexes
| Epitope | Target receptor | Score | Area | ACE value |
|---|---|---|---|---|
| VLGSSVQTA | 1TVD | 5574 | 616.10 | − 134.28 |
| VNIELKPEF | 1TVD | 6508 | 760.20 | − 151.62 |
| VVPSNLFAV | 1TVD | 6508 | 736.30 | − 203.37 |
Fig. 7Docking complex with surface interaction (a) and bond length representation (b) of VLGSSVQTA epitope with 1TVD
Fig. 8Docking complex with surface interaction (a) and bond length representation (b) of VNIELKPEF epitope with 1TVD
Fig. 9Docking complex with surface interaction (a) and bond length representation (b) of VVPSNLFAV epitope with 1TVD